Loading...

Daxor Corporation

DXR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$10.54
$0.77(7.88%)
U.S. Market is Open • 10:18

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap51.7M
P/E Ratio5.85
EPS (TTM)$1.64
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$9.28
3 Months$12.96
1 Year Target$16.49

DXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Daxor Corporation (DXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.85 and a market capitalization of 51.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.02%
5-Day Change
7.89%
1-Month Change
0.29%
3-Month Change
-18.51%
6-Month Change
-25.54%
Year-to-Date (YTD) Change
-30.44%
1-Year Change
32.05%
3-Year Change
-8.15%
5-Year Change
3.12%
All-Time (Max) Change
8.00%

Contact Information

https://www.daxor.com
12123308500
109 Meco Lane, Oak Ridge, TN, 37830

Company Facts

37 Employees
IPO DateJul 25, 1983
CountryUS
Actively Trading

Frequently Asked Questions